Howard J. Dreskin
Corporate Officer/Principal at Optimer Pharmaceuticals LLC
Profile
Howard J.
Dreskin is currently the Director-Clinical Operations at Optimer Pharmaceuticals LLC since 2007.
Prior to this, he worked as the Director-Clinical Study & Data Management at Pfizer Inc. and as the Associate Director-Worldwide Clinical Safety at Smithkline Beecham Pharmaceuticals (India) Ltd.
He completed his graduate degree from Rutgers State University of New Jersey and his undergraduate degree from the University of Akron.
Howard J. Dreskin active positions
| Companies | Position | Start |
|---|---|---|
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | 2011-05-03 |
Former positions of Howard J. Dreskin
| Companies | Position | End |
|---|---|---|
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Training of Howard J. Dreskin
| University of Akron | Undergraduate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
- Stock Market
- Insiders
- Howard J. Dreskin
